Biologics RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis byJosh SandbergJune 30, 2015
Uncategorized SpineGuard Obtains Regulatory Clearance to Sell PediGuard® in the World’s Second-Largest Spine Market: China byJosh SandbergJune 30, 2015
Spine Centinel Spine™ is Granted the First Cervical Multilevel Indication for Its STALIF C® Integrated Interbody™ Device byJosh SandbergJune 30, 2015
Recon Orthofix Announces the Addition of Lilly Marks to Board of Directors byJosh SandbergJune 25, 2015
Recon Bacterin International Holdings, Inc. Awarded Agreement With Premier, Inc. byJosh SandbergJune 25, 2015
Uncategorized Smith & Nephew to acquire Zimmer’s Unicondylar Knee system in US market byJosh SandbergJune 25, 2015
Extremities Hospitals TissueGene, Inc. Announces FDA Acceptance Of Invossa™ As Proprietary Name For TissueGene-C byJosh SandbergJune 24, 2015
